EpiVax, Inc.-Strategic SWOT Analysis Review

EpiVax, Inc.-Strategic SWOT Analysis Review


  • Products Id :- GDPH136637SA
  • |
  • Pages: 34
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

EpiVax, Inc.-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-GlobalData's summarization of the company's business strategy.

SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Highlights

EpiVax, Inc. (EpiVax) is an immunology company which develops analytical capabilities in the field of computational immunology. Its product pipeline includes Tregitopes; deimmunization projects including deimmunized botox and deimmunized FVIII; and biodefense vaccines. Tregitopes are linear sequences of amino acids which activate natural regulatory T cells. It is an immune-modulation power tool being developed for auto-immune, auto-inflammatory and allergic conditions. EpiVax' service portfolio includes, immune engineering, immunogenicity screening, vaccine design and redesign. It also provides lab services such as in vivo, in vitro and ex vivo immunogenicity screening services including cell-free HLA binding assays. EpiVax is headquartered in Providence, Rhode Island, the US.

EpiVax, Inc. Key Recent Developments

Jan 11, 2016: EpiVax spins out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016

Jun 30, 2015: Designing the future at EpiVax

Jun 25, 2015: Exploring the Link between Polio Vaccination and Hand Foot Mouth Disease

Jun 09, 2015: USD 5.2 Million Department of Defense Grant Awarded to Vaccine on Demand Consortium

Jun 08, 2015: USD 5.2 Million Department of Defense Grant to Vaccine on Demand Consortium

Reasons To Buy

Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Section 1-About the Company 6

EpiVax, Inc.-Key Facts 6

EpiVax, Inc.-Key Employees 7

EpiVax, Inc.-Key Employee Biographies 8

EpiVax, Inc.-Key Operational Employees 9

EpiVax, Inc.-Major Products and Services 10

EpiVax, Inc.-Pharmaceutical Pipeline Products Data 11

EpiVax, Inc., Pipeline Products by Therapy Area 11

EpiVax, Inc., Pipeline Products by Development Phase 12

EpiVax, Inc.-History 14

EpiVax, Inc.-Company Statement 18

EpiVax, Inc.-Locations And Subsidiaries 19

Head Office 19

Section 2-Company Analysis 20

EpiVax, Inc.-Business Description 20

EpiVax, Inc.-SWOT Analysis 21

SWOT Analysis-Overview 21

EpiVax, Inc.-Strengths 21

Strength-EpiMatrix 21

Strength-Service Portfolio 21

Strength-Research Grants 21

EpiVax, Inc.-Weaknesses 22

Weakness-Lack of Marketed Products 22

EpiVax, Inc.-Opportunities 23

Opportunity-Effective Treatment of Hemophilia 23

Opportunity-Market Potential: Influenza Diseases 23

Opportunity-Strategic Partnerships 23

EpiVax, Inc.-Threats 24

Threat-Competitive Pressures 24

Threat-Increased Regulation 24

Threat-Uncertain R&D Outcomes 24

EpiVax, Inc.-Key Competitors 25

Section 3-Company's Lifesciences Financial Deals and Alliances 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

EpiVax, Inc., Recent Deals Summary 28

Section 4-Company's Recent Developments 29

Jan 11, 2016: EpiVax spins out Aceno Biotherapeutics at JP Morgan/Biotech Showcase 2016 29

Jun 30, 2015: Designing the future at EpiVax 30

Jun 25, 2015: Exploring the Link between Polio Vaccination and Hand Foot Mouth Disease 31

Jun 09, 2015: USD 5.2 Million Department of Defense Grant Awarded to Vaccine on Demand Consortium 32

Jun 08, 2015: USD 5.2 Million Department of Defense Grant to Vaccine on Demand Consortium 33

Section 5-Appendix 34

Methodology 34

About GlobalData 34

Contact Us 34

Disclaimer 34

List of Figures

EpiVax, Inc., Pipeline Products by Therapy Area 11

EpiVax, Inc., Pipeline Products by Development Phase 12

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 27

List of Tables

EpiVax, Inc., Key Facts 6

EpiVax, Inc., Key Employees 7

EpiVax, Inc., Key Employee Biographies 8

EpiVax, Inc., Key Operational Employees 9

EpiVax, Inc., Major Products and Services 10

EpiVax, Inc., Number of Pipeline Products by Therapy Area 11

EpiVax, Inc., Number of Pipeline Products by Development Stage 12

EpiVax, Inc., Pipeline Products By Therapy Area and Development Phase 13

EpiVax, Inc., History 14

EpiVax, Inc., Key Competitors 25

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 26

EpiVax, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016 27

EpiVax, Inc., Recent Deals Summary 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

VBI Vaccines Inc.

MVP Laboratories, Inc.

BioFactura, Inc.

Altravax, Inc.

Advanced BioScience Laboratories, Inc.

EpiVax, Inc., SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license

Single User License
USD 125 INR 8431
Site License
USD 250 INR 16863
Corporate User License
USD 375 INR 25294

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com